Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols. (Q45964819)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols. |
scientific article |
Statements
1 reference
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols. (English)
1 reference
Martin Schrappe
1 reference
Martin Stanulla
1 reference
Anja Möricke
1 reference
Sally A Coulthard
1 reference
Gunnar Cario
1 reference
André Schrauder
1 reference
Peter Kaatsch
1 reference
Michael Dördelmann
1 reference
Karl Welte
1 reference
Martin Zimmermann
1 reference
Alfred Reiter
1 reference
Michel Eichelbaum
1 reference
Hansjörg Riehm
1 reference
Matthias Schwab
1 reference
17 June 2009
1 reference
1 reference
114
1 reference
7
1 reference
1314-1318
1 reference
Identifiers
1 reference
1 reference